Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
3.520
+0.220 (6.67%)
At close: Oct 20, 2025, 4:00 PM EDT
3.546
+0.026 (0.74%)
After-hours: Oct 20, 2025, 6:25 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $898.87 million as of October 20, 2025. Its market cap has decreased by -19.62% in one year.
Market Cap
898.87M
Enterprise Value
943.87M
1-Year Change
-19.62%
Ranking
Category
Stock Price
$3.52
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $2.43B to $898.87M, a decrease of -63.00%. That is a compound annual growth rate of -18.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 477.44M | -38.24% |
| Dec 31, 2024 | 773.05M | -10.72% |
| Dec 29, 2023 | 865.84M | -54.00% |
| Dec 30, 2022 | 1.88B | -65.83% |
| Dec 31, 2021 | 5.51B | 100.45% |
| Dec 31, 2020 | 2.75B | 13.12% |
| Nov 20, 2020 | 2.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |